Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches

Long-term liver injuries lead to hepatic fibrosis, often progressing into cirrhosis, liver failure, portal hypertension, and hepatocellular carcinoma. There is currently no effective therapy available for liver fibrosis. Thus, continuous investigations for anti-fibrotic therapy are ongoing. The main...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammed, Omima S., Attia, Hany G., Mohamed, Bassim M. S. A., Elbaset, Marawan A., Fayed, Hany M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Science Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662312/
https://www.ncbi.nlm.nih.gov/pubmed/38022905
http://dx.doi.org/10.3389/jpps.2023.11808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662312/
https://www.ncbi.nlm.nih.gov/pubmed/38022905
http://dx.doi.org/10.3389/jpps.2023.11808

Ejemplares similares